185 related articles for article (PubMed ID: 11999897)
21. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
22. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.
Rostami-Hodjegan A; Amin AM; Spencer EP; Lennard MS; Tucker GT; Flanagan RJ
J Clin Psychopharmacol; 2004 Feb; 24(1):70-8. PubMed ID: 14709950
[TBL] [Abstract][Full Text] [Related]
23. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
[TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
25. Clozapine monitoring: plasma or serum levels?
Kaladjian A; Bery B; Deturmeny E; Bruguerolle B
Ther Drug Monit; 1999 Jun; 21(3):327-9. PubMed ID: 10365647
[TBL] [Abstract][Full Text] [Related]
26. Determination of clozapine and its metabolite, norclozapine in various biological matrices using high-performance liquid chromatography.
Rosland M; Szeto P; Procyshyn R; Barr AM; Wasan KM
Drug Dev Ind Pharm; 2007 Oct; 33(10):1158-66. PubMed ID: 17963117
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances.
Lu ML; Lane HY; Lin SK; Chen KP; Chang WH
J Clin Psychiatry; 2004 Jun; 65(6):766-71. PubMed ID: 15291653
[TBL] [Abstract][Full Text] [Related]
28. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
[TBL] [Abstract][Full Text] [Related]
29. Suspected clozapine poisoning in the UK/Eire, 1992-2003.
Flanagan RJ; Spencer EP; Morgan PE; Barnes TR; Dunk L
Forensic Sci Int; 2005 Dec; 155(2-3):91-9. PubMed ID: 16226146
[TBL] [Abstract][Full Text] [Related]
30. Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.
Turrion MC; Perez J; Bernardo M; Fernandez-Egea E
Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(1):31-35. PubMed ID: 31122757
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of clozapine, norclozapine and clozapine-N-oxide in human plasma by high-performance liquid chromatography with ultraviolet detection.
Liu YY; van Troostwijk LJ; Guchelaar HJ
Biomed Chromatogr; 2001 Jun; 15(4):280-6. PubMed ID: 11438972
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
Ming DS; Heathcote J
J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
[TBL] [Abstract][Full Text] [Related]
33. Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
Flanagan RJ; Hunter S; Obee SJ; Reeves S
J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):131-138. PubMed ID: 36735578
[TBL] [Abstract][Full Text] [Related]
34. A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration.
Couchman L; Belsey SL; Handley SA; Flanagan RJ
Anal Bioanal Chem; 2013 Nov; 405(29):9455-66. PubMed ID: 24091736
[TBL] [Abstract][Full Text] [Related]
35. Making sense of norclozapine levels: 3 clinical axioms.
Meyer JM
Schizophr Res; 2024 Jun; 268():289-292. PubMed ID: 37945386
[TBL] [Abstract][Full Text] [Related]
36. Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics.
Li CH; Stratford RE; Velez de Mendizabal N; Cremers TI; Pollock BG; Mulsant BH; Remington G; Bies RR
J Transl Med; 2014 Aug; 12():203. PubMed ID: 25142323
[TBL] [Abstract][Full Text] [Related]
37. Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection.
Bondesson U; Lindström LH
Psychopharmacology (Berl); 1988; 95(4):472-5. PubMed ID: 3145517
[TBL] [Abstract][Full Text] [Related]
38. Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders.
Migliardi G; D'Arrigo C; Santoro V; Bruno A; Cortese L; Campolo D; Cacciola M; Spina E
Clin Neuropharmacol; 2007; 30(2):107-13. PubMed ID: 17414943
[TBL] [Abstract][Full Text] [Related]
39. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
[TBL] [Abstract][Full Text] [Related]
40. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
